By exploiting the newly discovered link between ZNF224 and c-Myc downstream of Bcr-Abl in CML, we show that ZNF224 expression is induced by AG490 in both sensitive and imatinib-resistant K562 cells. Here, ZNF224 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.